Thursday, 25 April 2024
ETF Series Solutions - Loncar Cancer Immunothera
NASDAQ : CNCR
14.63 14 Oct 22 00:00 | Change: 0.29 | Open: 14.98 | High: 15.11 | Ask: 0.00 | Volume: 6,500 |
Change(%): 1.91 | Prev: 14.92 | Low: 14.60 | Bid: 0.00 | Avg vol: 0 |
00:37 | 12/1/18
Danville Daily
The twenty one day Wilder Moving Average has been seen above the fifty day Simple Moving Average on shares of Loncar Cancer Immunotherapy ETF (CNCR). Traders following these lines may be tracking the stock and checking for a strong near-term trend. Let ...
more»
09:37 | 1/1/18
Press Telegraph
More notable recent Loncar Cancer Immunotherapy ETF (NASDAQ:CNCR) news were published by: Seekingalpha.com which released: “The First Cancer Immunotherapy ETF” on October 16, 2015, also Seekingalpha.
more»
10:00 | 24/12/17
Frisco Fastball
More notable recent Loncar Cancer Immunotherapy ETF (NASDAQ:CNCR) news were published by: Seekingalpha.com which released: “The First Cancer Immunotherapy ETF” on October 16, 2015, also Seekingalpha.
more»
10:11 | 15/12/17
BZ Weekly
More notable recent Loncar Cancer Immunotherapy ETF (NASDAQ:CNCR) news were published by: Seekingalpha.com which released: “The First Cancer Immunotherapy ETF” on October 16, 2015, also Seekingalpha.
more»
09:48 | 10/12/17
WeeklyHub
The ETF increased 2.06% or $0.5 during the last trading session, reaching $24.78. About 6,418 shares traded. Loncar Cancer Immunotherapy ETF (NASDAQ:CNCR) has risen 4.13% since December 9, 2016 and is uptrending. It has underperformed by 12.57% the S ...
more»
There are currently no comments on this topic.
Be the first person to Add a Comment...
You must be a registered user to post a comment: REGISTER NOW
If you are already registered, please LOGIN NOW
|
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |